55 related articles for article (PubMed ID: 3499120)
21. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis.
Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC
Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911
[TBL] [Abstract][Full Text] [Related]
22. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer.
Kadoyama C; Kimura H; Yamaguchi Y
Jpn J Clin Oncol; 1987 Mar; 17(1):29-39. PubMed ID: 2951535
[TBL] [Abstract][Full Text] [Related]
24. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
25. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
26. Surgical strategy for non-small cell lung cancer in octogenarians.
Ikeda N; Hayashi A; Iwasaki K; Kajiwara N; Uchida O; Kato H
Respirology; 2007 Sep; 12(5):712-8. PubMed ID: 17875060
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
Mizutani Y; Okada Y; Terachi T; Yoshida O
J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
29. [Surgery for intrathoracic recurrence of non-small cell lung cancer].
Ohkubo T; Okayasu T; Hashimoto M; Shiiya N; Konishi K; Motohara T; Katoh H
Kyobu Geka; 2000 Feb; 53(2):127-31. PubMed ID: 10667023
[TBL] [Abstract][Full Text] [Related]
30. [Long-term results after recurrence of completely resected primary lung cancer].
Togashi K; Saito M; Asami F; Sato H; Niyoshi S; Tanba H
Kyobu Geka; 2006 Dec; 59(13):1137-40; discussion 1140-3. PubMed ID: 17163204
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma.
Bodendorf MO; Haas V; Laberke HG; Blumenstock G; Wex P; Graeter T
Lung Cancer; 2009 Apr; 64(1):71-8. PubMed ID: 18790545
[TBL] [Abstract][Full Text] [Related]
32. [Lysosomal enzymes and natural killer activity].
Bulychev AG; Blinova TV
Tsitologiia; 1991; 33(2):76-9. PubMed ID: 1926574
[TBL] [Abstract][Full Text] [Related]
33. [Study of the natural killer cell activity in lung cancer patients].
Lin CC; Kuo YC; Lin CY; Huang WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 May; 20(2):113-8. PubMed ID: 3652779
[TBL] [Abstract][Full Text] [Related]
34. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients.
Uchida A; Kariya Y; Okamoto N; Sugie K; Fujimoto T; Yagita M
J Natl Cancer Inst; 1990 Nov; 82(21):1697-701. PubMed ID: 2231757
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
Yasumoto K; Ohta M; Nomoto K
Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
[TBL] [Abstract][Full Text] [Related]
36. Effect of radiotherapy on lymphocyte cytotoxicity against allogeneic lung cancer cells in patients with bronchogenic carcinoma.
Toyohira K; Yasumoto K; Manabe H; Ohta M; Terashima H; Takayama K; Shinohara S; Nomoto K
Gan; 1979 Feb; 70(1):9-14. PubMed ID: 446978
[TBL] [Abstract][Full Text] [Related]
37. [Changes in the cytostatic and cytotoxic activities of the peripheral blood lymphocytes in the surgical treatment of lung cancer patients].
Polushina OA; Lian NV; Bogdashin IV
Vopr Onkol; 1992; 38(2):173-7. PubMed ID: 1300702
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of non-MHC-restricted killer cell activity in lung cancer.
Malygin AM; Redjko AA; Pogodina ON; Karaseva NA; Koval YF; Timonen T
Cancer Immunol Immunother; 1993; 36(1):61-4. PubMed ID: 8422669
[TBL] [Abstract][Full Text] [Related]
39. Relationship of curative surgery on natural killer cell activity in colorectal cancer.
Espí A; Arenas J; García-Granero E; Martí E; Lledó S
Dis Colon Rectum; 1996 Apr; 39(4):429-34. PubMed ID: 8878504
[TBL] [Abstract][Full Text] [Related]
40. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.
Vánky F; Péterffy A; Böök K; Willems J; Klein E; Klein G
Cancer Immunol Immunother; 1983; 16(1):17-22. PubMed ID: 6605800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
